Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaj Blennow

Showing results (1-10 of 2,241) with videos related to

Pageof 225
Sort By:
Expert Review of Molecular Diagnostics|September 10, 2005
CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatmentKaj Blennow
Nature Reviews. Neurology|February 8, 2011
Dementia in 2010: Paving the way for Alzheimer disease drug developmentKaj Blennow
Nature Medicine|November 6, 2010
Biomarkers in Alzheimer's disease drug developmentKaj Blennow
Neurology and Therapy|July 23, 2017
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to BloodKaj Blennow
Science (New York, N.Y.)|August 6, 2021
Phenotyping Alzheimer's disease with blood testsKaj Blennow
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Cerebrospinal fluid protein biomarkers for Alzheimer's diseaseKaj Blennow
The Medical Clinics of North America|May 7, 2013
The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer diseaseKaj Blennow, Henrik Zetterberg
Journal of Alzheimer'S Disease : JAD|March 23, 2018
The Past and the Future of Alzheimer's Disease Fluid BiomarkersKaj Blennow, Henrik Zetterberg
Peptides|July 20, 2002
Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's diseaseNiels Andreasen, Kaj Blennow
Journal of Alzheimer'S Disease : JAD|May 16, 2018
From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's DiseaseHenrik Zetterberg, Kaj Blennow
Pageof 225

Showing results (1-10 of 2,241) with videos related to

Sort By:
Pageof 225
Expert Review of Molecular Diagnostics|September 10, 2005
CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatmentKaj Blennow
Nature Reviews. Neurology|February 8, 2011
Dementia in 2010: Paving the way for Alzheimer disease drug developmentKaj Blennow
Nature Medicine|November 6, 2010
Biomarkers in Alzheimer's disease drug developmentKaj Blennow
Neurology and Therapy|July 23, 2017
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to BloodKaj Blennow
Science (New York, N.Y.)|August 6, 2021
Phenotyping Alzheimer's disease with blood testsKaj Blennow
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Cerebrospinal fluid protein biomarkers for Alzheimer's diseaseKaj Blennow
The Medical Clinics of North America|May 7, 2013
The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer diseaseKaj Blennow, Henrik Zetterberg
Journal of Alzheimer'S Disease : JAD|March 23, 2018
The Past and the Future of Alzheimer's Disease Fluid BiomarkersKaj Blennow, Henrik Zetterberg
Peptides|July 20, 2002
Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's diseaseNiels Andreasen, Kaj Blennow
Journal of Alzheimer'S Disease : JAD|May 16, 2018
From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's DiseaseHenrik Zetterberg, Kaj Blennow
Pageof 225